Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA001522 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA001522, RRID:AB_1079285
- Product name
- Anti-LUM
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human LUM, Gene description: lumican, Alternative Gene Names: LDC, SLRR2D, Validated applications: IHC, Uniprot ID: P51884, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.05 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Stromal expression of cancer‑associated fibroblast‑related molecules, versican and lumican, is strongly associated with worse relapse‑free and overall survival times in patients with esophageal squamous cell carcinoma
Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide
Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion
Lumican and versican are associated with good outcome in stage II and III colon cancer.
Yamauchi N, Kanke Y, Saito K, Okayama H, Yamada S, Nakajima S, Endo E, Kase K, Yamada L, Nakano H, Matsumoto T, Hanayama H, Watanabe Y, Hayase S, Saito M, Saze Z, Mimura K, Momma T, Oki S, Hashimoto Y, Kono K
Oncology Letters 2021;21(6)
Oncology Letters 2021;21(6)
Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide
Jeanne A, Untereiner V, Perreau C, Proult I, Gobinet C, Boulagnon-Rombi C, Terryn C, Martiny L, Brézillon S, Dedieu S
Scientific Reports 2017;7(1)
Scientific Reports 2017;7(1)
Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
de Wit M, Carvalho B, Delis-van Diemen PM, van Alphen C, Beliën JAM, Meijer GA, Fijneman RJA
PloS one 2017;12(5):e0174768
PloS one 2017;12(5):e0174768
Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion
Vellinga T, den Uil S, Rinkes I, Marvin D, Ponsioen B, Alvarez-Varela A, Fatrai S, Scheele C, Zwijnenburg D, Snippert H, Vermeulen L, Medema J, Stockmann H, Koster J, Fijneman R, de Rooij J, Kranenburg O
Oncogene 2016;35(40):5263-5271
Oncogene 2016;35(40):5263-5271
Lumican and versican are associated with good outcome in stage II and III colon cancer.
de Wit M, Belt EJ, Delis-van Diemen PM, Carvalho B, Coupé VM, Stockmann HB, Bril H, Beliën JA, Fijneman RJ, Meijer GA
Annals of surgical oncology 2013 Dec;20 Suppl 3(Suppl 3):S348-59
Annals of surgical oncology 2013 Dec;20 Suppl 3(Suppl 3):S348-59
No comments: Submit comment
No validations: Submit validation data